论文部分内容阅读
目的探究妊娠期产妇合并不同妇科肿瘤的处理方法及其妊娠结局。方法对妇产科1678例妊娠期产妇的临床资料进行回顾性分析,比较在妊娠期同时患有妇科肿瘤的245例产妇(观察组)和未患有妇科肿瘤的1433例产妇(对照组)生育情况。结果观察组妊娠期合并妇科肿瘤产妇的主要肿瘤类型为子宫肌瘤[占63.67%(156/245)]和卵巢癌[占31.02%(76/245)]。观察组妊娠期合并妇科肿瘤患者的剖宫产率达到100.00%(245/245),而未合并妇科肿瘤的对照组产妇剖宫产率为23.94%(343/1433)。两组剖宫产率比较,差异有统计学意义(P<0.05)。观察组妊娠期合并妇科肿瘤产妇的妊娠并发症发生率为7.35%(18/245)、胎儿并发症4.90%(12/245)、胎儿生存率95.92%(235/245)。对照组妊娠并发症发生率为9.07%(130/1433)、胎儿并发症3.77%(54/1433)、胎儿生存率97.35%(1395/1433),两组胎儿生存率之间差异无统计学意义(P>0.05)。结论产妇经产检诊断合并妇科肿瘤后应立即采取相关处理手段,帮助产妇度过高危期,再进行剖宫产术,人工协助产妇分娩的同时摘除肿瘤部位。正确的临床处理能够减少胎儿并发症的发生,降低死亡率,值得临床借鉴和推广。
Objective To investigate the treatment of pregnant women with different gynecologic tumors and their pregnancy outcomes. Methods The clinical data of 1678 pregnant women in obstetrics and gynecology were retrospectively analyzed. The data of 245 maternal women (observation group) and 1433 maternal women without gynecologic tumor (control group) during pregnancy were compared. Happening. Results The main tumor types of women with gynecologic tumor during pregnancy were uterine fibroids [63.67% (156/245)] and ovarian cancer [31.02% (76/245)]. The rate of cesarean section in the observation group was 100.00% (245/245) in pregnant women with gynecologic tumor, while that in the control group without gynecological tumor was 23.94% (343/1433). Cesarean section rate between the two groups, the difference was statistically significant (P <0.05). The incidence of pregnancy complications in observation group were 7.35% (18/245), 4.90% (12/245) and 95.92% (235/245) in fetus with gynecologic tumor during pregnancy. The incidence of pregnancy complications in control group was 9.07% (130/1433), fetal complications was 3.77% (54/1433) and fetal survival rate was 97.35% (1395/1433). There was no significant difference in fetal survival rate between the two groups (P> 0.05). Conclusions The maternal examination should be taken immediately after the diagnosis of gynecologic cancer, to help maternal over high risk period, and then to carry out cesarean section and assisted labor to remove the tumor site while giving birth. Correct clinical treatment can reduce the incidence of fetal complications, reduce mortality, it is worth clinical reference and promotion.